안과용 기기 시장 규모, 점유율, 성장률 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of ophthalmic devices Market

The global ophthalmic devices market was valued at USD 31.45 billion in 2025 and is projected to grow to USD 32.9 billion in 2026, reaching USD 48.44 billion by 2034, representing a CAGR of 5% during the forecast period. North America dominated the market in 2025 with a 40.92% share, driven by the widespread adoption of advanced intraocular lenses (IOLs), high volumes of ophthalmic surgeries, and a strong presence of major market players.

The market encompasses ophthalmic diagnostics and surgical devices, as well as vision care products such as contact lenses and ocular health devices. Increasing prevalence of vision disorders, including myopia, high myopia, cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration, is driving demand globally. According to the World Health Organization (WHO) and Brien Holden Vision Institute, by 2050, approximately 52% of the global population is expected to be affected by myopia and 10% by high myopia, highlighting the growing need for ophthalmic devices.

Market Drivers

The increasing prevalence of vision disorders, along with the rise in eye surgeries, is the primary driver for market growth. For instance, in the U.S., approximately 3.9 million cataract surgeries were performed in 2018, reflecting the growing demand for surgical devices. Additionally, technological advancements, such as the development of micro-invasive glaucoma (MIGs) surgical implants and trifocal intraocular lenses, have further propelled market growth.

Other drivers include favorable reimbursement policies, rising per capita healthcare expenditure, and increasing patient awareness of eye health. Vision care devices, particularly contact lenses, have seen higher adoption rates, with an estimated 45 million people in the U.S. using contact lenses, contributing significantly to the vision care segment.

Market Restraints

The high cost of ophthalmic devices limits growth in emerging countries. For example, femtosecond lasers cost between USD 200,000 and USD 400,000, making them less accessible to small and mid-sized clinics. Additionally, low treatment rates in emerging nations due to limited healthcare infrastructure, product accessibility, and patient awareness continue to restrain market expansion.

Impact of COVID-19

The COVID-19 pandemic negatively impacted the market, particularly the surgical segment, as ophthalmic procedures declined significantly. An analysis of 228 hospitals in the U.S. showed an 81% reduction in ophthalmology patient visits during March-April 2020, with cataract surgeries declining by 97%. Conversely, vision care devices such as eye-drops saw increased demand due to panic-buying and stockpiling amid lockdowns.

Segmentation Analysis

By Product:

• Vision care devices dominate the market, driven by rising adoption of contact lenses and ocular health products.
• Surgical devices are also growing due to innovations in intraocular lenses (IOLs) and the increasing number of cataract and retinal surgeries. For example, in 2019, Alcon launched the AcrySof IQ PanOptix Trifocal IOL, a key innovation in the U.S.

By End User:

• Ophthalmic clinics hold the largest market share due to advantages such as shorter waiting times and adoption of advanced devices.
• The others segment, including ambulatory surgical centers (ASCs) and multispecialty clinics, is witnessing growing demand in the U.S. and Europe.

Regional Insights

• North America: Valued at USD 12.87 billion in 2025 and projected at USD 13.46 billion in 2026, with the U.S. accounting for USD 12.61 billion in 2026, fueled by advanced IOL adoption and a strong presence of key players.
• Europe: Expected growth is significant, with the UK market projected at USD 1.03 billion and Germany at USD 2.31 billion in 2026, supported by government investments and innovative product launches like Alcon's Vivity IOL.
• Asia Pacific: Rapid growth is projected due to rising incidence of cataract, glaucoma, and dry eye disease. The Japan market is projected at USD 2.77 billion, China at USD 3.71 billion, and India at USD 0.73 billion in 2026.
• Latin America & Middle East/Africa: Market growth is driven by increasing manufacturer presence and rising awareness of contact lenses.

Key Players and Industry Developments

Leading companies include Alcon, Johnson & Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec, Cooper Companies, Inc., Essilor, Hoya Corporation, and NIDEK CO., LTD. These players are focused on R&D, product innovation, and geographical expansion to strengthen their market positions.

Recent developments include:

• July 2021: CooperVision launched Clarity 1-day as the first net plastic-neutral contact lens in the U.S.
• Nov 2020: Alcon presented pivotal data on AcrySof IQ Vivity IOL at the AAO 2020 virtual meeting.
• Sept 2020: ZEISS International launched ZEISS UVClean disinfecting device for optometry clinics.
• July 2020: Hoya launched Sensity Fast light-reactive lenses in the photochromic category.

Conclusion

The ophthalmic devices market is projected to grow from USD 31.45 billion in 2025 to USD 48.44 billion by 2034 at a CAGR of 5%, driven by rising prevalence of vision disorders, growing adoption of advanced devices, and increasing ophthalmic surgeries. While high device costs and low treatment rates in emerging nations remain challenges, technological advancements, innovative product launches, and expanding vision care awareness are expected to sustain market growth across all regions.

Segmentation By Product Type

• Surgical
  • Implants
  • Consumables
  • Equipment
• Vision Care
  • Contact Lens
  • Ocular Health

By End-user

• Hospitals
• Ophthalmic Clinics
• Others

By Geography

• North America
  • By Product
  • By End User
  • By Country
• Europe
  • By Product
  • By End User
  • By Country/Sub-region
• Asia Pacific
  • By Product
  • By End User
  • By Country/Sub-region
• Latin America
  • By Product
  • By End User
  • By Country/Sub-region
• The Middle East & Africa
  • By Product
  • By End User
  • By Country/Sub-region

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2025
• 4.2. Epidemiology of Major Ocular Disease - For Key Countries
• 4.3. Introduction of New Products / Approvals (by Major Players)
• 4.4. Overview of Regulatory Scenario - Key Countries
• 4.5. Technological Advancements in Ophthalmic Devices Market

5. Global Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product Type
  • 5.2.1. Surgical
    • 5.2.1.1. Implants
    • 5.2.1.2. Consumables
    • 5.2.1.3. Equipment
  • 5.2.2. Vision Care
    • 5.2.2.1. Contact Lenses
    • 5.2.2.2. Intraocular Lenses
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals
  • 5.3.2. Ophthalmic Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Product Type
  • 6.2.1. Surgical
    • 6.2.1.1. Implants
    • 6.2.1.2. Consumables
    • 6.2.1.3. Equipment
  • 6.2.2. Vision Care
    • 6.2.2.1. Contact Lenses
    • 6.2.2.2. Intraocular Lenses
• 6.3. Market Analysis - By End-user
  • 6.3.1. Hospitals
  • 6.3.2. Ophthalmic Clinics
  • 6.3.3. Others
• 6.4. Market Analysis - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Product Type
  • 7.2.1. Surgical
    • 7.2.1.1. Implants
    • 7.2.1.2. Consumables
    • 7.2.1.3. Equipment
  • 7.2.2. Vision Care
    • 7.2.2.1. Contact Lenses
    • 7.2.2.2. Intraocular Lenses
• 7.3. Market Analysis - By End-user
  • 7.3.1. Hospitals
  • 7.3.2. Ophthalmic Clinics
  • 7.3.3. Others
• 7.4. Market Analysis - By Country/ Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Product Type
  • 8.2.1. Surgical
    • 8.2.1.1. Implants
    • 8.2.1.2. Consumables
    • 8.2.1.3. Equipment
  • 8.2.2. Vision Care
    • 8.2.2.1. Contact Lenses
    • 8.2.2.2. Intraocular Lenses
• 8.3. Market Analysis - By End-user
  • 8.3.1. Hospitals
  • 8.3.2. Ophthalmic Clinics
  • 8.3.3. Others
• 8.4. Market Analysis - By Country/ Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Product Type
  • 9.2.1. Surgical
    • 9.2.1.1. Implants
    • 9.2.1.2. Consumables
    • 9.2.1.3. Equipment
  • 9.2.2. Vision Care
    • 9.2.2.1. Contact Lenses
    • 9.2.2.2. Intraocular Lenses
• 9.3. Market Analysis - By End-user
  • 9.3.1. Hospitals
  • 9.3.2. Ophthalmic Clinics
  • 9.3.3. Others
• 9.4. Market Analysis - By Country/ Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Product Type
  • 10.2.1. Surgical
    • 10.2.1.1. Implants
    • 10.2.1.2. Consumables
    • 10.2.1.3. Equipment
  • 10.2.2. Vision Care
    • 10.2.2.1. Contact Lenses
    • 10.2.2.2. Intraocular Lenses
• 10.3. Market Analysis - By End-user
  • 10.3.1. Hospitals
  • 10.3.2. Ophthalmic Clinics
  • 10.3.3. Others
• 10.4. Market Analysis - By Country/ Sub-region
  • 10.4.1. GCC Countries
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2021)
• 11.3. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  • 11.3.1. Alcon (Part of Novartis AG)
    • 11.3.1.1. Overview,
    • 11.3.1.2. Products,
    • 11.3.1.3. SWOT analysis,
    • 11.3.1.4. Recent developments,
    • 11.3.1.5. strategies,
    • 11.3.1.6. financials (based on availability)
  • 11.3.2. Johnson & Johnson Services, Inc.
    • 11.3.2.1. Overview,
    • 11.3.2.2. Products,
    • 11.3.2.3. SWOT analysis,
    • 11.3.2.4. Recent developments,
    • 11.3.2.5. strategies,
    • 11.3.2.6. financials (based on availability)
  • 11.3.3. Essilor
    • 11.3.3.1. Overview,
    • 11.3.3.2. Products,
    • 11.3.3.3. SWOT analysis,
    • 11.3.3.4. Recent developments,
    • 11.3.3.5. strategies,
    • 11.3.3.6. financials (based on availability)
  • 11.3.4. Bausch Health Companies
    • 11.3.4.1. Overview,
    • 11.3.4.2. Products,
    • 11.3.4.3. SWOT analysis,
    • 11.3.4.4. Recent developments,
    • 11.3.4.5. strategies,
    • 11.3.4.6. financials (based on availability)
  • 11.3.5. ZEISS International
    • 11.3.5.1. Overview,
    • 11.3.5.2. Products,
    • 11.3.5.3. SWOT analysis,
    • 11.3.5.4. Recent developments,
    • 11.3.5.5. strategies,
    • 11.3.5.6. financials (based on availability)
  • 11.3.6. HOYA
    • 11.3.6.1. Overview,
    • 11.3.6.2. Products,
    • 11.3.6.3. SWOT analysis,
    • 11.3.6.4. Recent developments,
    • 11.3.6.5. strategies,
    • 11.3.6.6. financials (based on availability)
  • 11.3.7. NIDEK CO., LTD
    • 11.3.7.1. Overview,
    • 11.3.7.2. Products,
    • 11.3.7.3. SWOT analysis,
    • 11.3.7.4. Recent developments,
    • 11.3.7.5. strategies,
    • 11.3.7.6. financials (based on availability)
  • 11.3.8. TOPCON
    • 11.3.8.1. Overview,
    • 11.3.8.2. Products,
    • 11.3.8.3. SWOT analysis,
    • 11.3.8.4. Recent developments,
    • 11.3.8.5. strategies,
    • 11.3.8.6. financials (based on availability)
  • 11.3.9. CooperVision
    • 11.3.9.1. Overview,
    • 11.3.9.2. Products,
    • 11.3.9.3. SWOT analysis,
    • 11.3.9.4. Recent developments,
    • 11.3.9.5. strategies,
    • 11.3.9.6. financials (based on availability)
  • 11.3.10. Other Prominent Players
    • 11.3.10.1. Overview,
    • 11.3.10.2. Products,
    • 11.3.10.3. SWOT analysis,
    • 11.3.10.4. Recent developments,
    • 11.3.10.5. strategies,
    • 11.3.10.6. financials (based on availability)